top of page

New Approach for Smarter, Safer Cancer Treatment

Published on University of California San Francisco (UCSF)


Researchers at UCSF have developed a groundbreaking personalized chemotherapy conditioning approach that has transformed outcomes for children with blood cancers undergoing stem cell transplants. By tailoring treatment based on genetics, kidney function, immune status, and other individual factors, survival rates have soared to nearly 90% while long-term side effects have been dramatically reduced. This innovation, pioneered by Dr. Christopher Dvorak and Dr. Janel Long-Boyle, marks a pivotal step in making pediatric cancer treatment both safer and more effective.



Disclaimer

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link. SSCTR does not provide medical advice, and the views expressed are for educational purposes only.

 
 
 

Comments


bottom of page